| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |